ARCHIVES

In Brief: NCAB Appointments: Boutwell Stay On; Brown, Elion, Strong, Korn Named; One Vacancy Remains

This article is from The Cancer Letter archive.

Vol. 10 No. 20 | May 18, 1984

Download PDF Visit The Full Archive

Related Articles

Votrient Trial Meets PFS Endpoint In Epithelial Ovarian Cancer

June 28, 2013

In Brief: Cancer Program A “Noble Venture,” Kennedy Says; $937 Million Not Enough, Upton Says

April 13, 1979

Carbone Names NCI Clinical Director, Rauscher shuffles Treatment Activities

August 30, 1974

In Brief: Cancer Program “Strengthened” NIH, Report From Biomedical Research Panel Contends

April 16, 1976

Tykerb And Trastuzumab Showed Increase In PFS For HER2+ Breast Cancer In Study

May 30, 2008

SWOG Closes Prostate Cancer Trial With Mitoxantrone

February 23, 2007